VBI Vaccines Inc. (TSE:VBV – Get Free Report) shares were down 5.1% on Monday . The company traded as low as C$4.82 and last traded at C$4.82. Approximately 1,300 shares traded hands during trading, a decline of 64% from the average daily volume of 3,637 shares. The stock had previously closed at C$5.08.
VBI Vaccines Trading Down 5.1 %
The firm has a market cap of C$308.86 million and a price-to-earnings ratio of -4.97. The company has a current ratio of 2.64, a quick ratio of 2.54 and a debt-to-equity ratio of 14.29.
About VBI Vaccines
VBI Vaccines Inc, a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus.
Further Reading
- Five stocks we like better than VBI Vaccines
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- EV Stocks and How to Profit from Them
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Financial Services Stocks Investing
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.
